Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Synaptogenix, Inc. | Chief Financial Officer | Common Stock, par value $0.0001 per share | 33.2K | $38.9K | $1.17 | Dec 16, 2022 | Direct |
Synaptogenix, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 75K | Nov 15, 2022 | Direct | ||
PharmaCyte Biotech, Inc. | Director | Stock Option (Right to Buy) | 38K | Apr 30, 2024 | Direct | ||
XWELL, Inc. | Director | Employee stock option (right to buy) | 30.8K | Nov 15, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
XWEL | XWELL, Inc. | Nov 15, 2024 | 1 | $0 | 4 | Nov 18, 2024 | Director |
PMCB | PharmaCyte Biotech, Inc. | Apr 30, 2024 | 1 | $0 | 4 | Jul 17, 2024 | Director |
PMCB | PharmaCyte Biotech, Inc. | Nov 20, 2023 | 1 | $0 | 4 | Nov 22, 2023 | Director |
XWEL | XWELL, Inc. | May 30, 2023 | 1 | $6.18K | 4 | May 31, 2023 | Director |
OBLG | Oblong, Inc. | May 29, 2023 | 0 | $0 | 3 | Jun 1, 2023 | Director |
XWEL | XWELL, Inc. | May 26, 2023 | 1 | $6.25K | 4 | May 30, 2023 | Director |
XWEL | XWELL, Inc. | Jan 5, 2023 | 1 | $0 | 4/A | Jan 9, 2023 | Director |
SNPX | Synaptogenix, Inc. | Dec 16, 2022 | 1 | -$31.6K | 4 | Dec 20, 2022 | Chief Financial Officer |
SNPX | Synaptogenix, Inc. | Nov 15, 2022 | 1 | $0 | 4/A | Dec 1, 2022 | Chief Financial Officer |
PMCB | PharmaCyte Biotech, Inc. | Nov 14, 2022 | 0 | $0 | 3 | Nov 16, 2022 | Director |
XWEL | XpresSpa Group, Inc. | Apr 20, 2022 | 1 | -$47.7K | 4 | Apr 22, 2022 | Director |
XWEL | XpresSpa Group, Inc. | Jan 26, 2022 | 2 | $0 | 4 | Jan 31, 2022 | Director |
XWEL | XpresSpa Group, Inc. | Jan 19, 2022 | 1 | -$70.2K | 4 | Jan 21, 2022 | Director |
XWEL | XpresSpa Group, Inc. | Oct 20, 2021 | 1 | -$90.2K | 4 | Oct 22, 2021 | Director |
XWEL | XpresSpa Group, Inc. | Jul 29, 2021 | 1 | $0 | 4 | Jul 30, 2021 | Director |
SNPX | Synaptogenix, Inc. | Jul 13, 2021 | 1 | $0 | 4 | Jul 15, 2021 | Chief Financial Officer |
SNPX | Synaptogenix, Inc. | Jun 4, 2021 | 0 | $0 | 3 | Jun 14, 2021 | Chief Financial Officer |